Clinical Medicine and Pharmacology Clinical Medicine and Pharmacology Клиническая медицина и фармакология 2409-3750 47963 10.12737/2409-3750-2021-7-3-38-40 Обзоры reviews Обзоры Modern views on osteoarthritis therapy Целесообразность традиционных методов терапии остеоартрита Фатенко А. С. Fatenko A. S. Беляева Елена Александровна Belyaeva Elena Aleksandrovna Тульский государственный университет Tula State University 23 12 2021 23 12 2021 7 3 38 40 23 12 2021 https://zh-szf.ru/en/nauka/article/47963/view

В обзоре рассмотрены влияние симптоматических препаратов замедленного действия, нестероидных противовоспалительных препаратов, гиалуроновой кислоты на течение и прогрессирование остеоартрита.

The review examines the effect of symptomatic delayed-acting drugs, nonsteroidal anti-inflammatory drugs, hyaluronic acid on the course and progression of osteoarthritis.

 нестероидные противовоспалительные препараты симптоматические препараты замедленного действия хондроитин глюкозамин гиалуроновая кислота. nonsteroidal anti-inflammatory drugs symptomatic delayed-action drugs chondroitin glucosamine hyaluronic acid.

Лила А.М., Алексеева Л.И., Таскина Е.А. Современные подходы к терапии остеоартрита с учетом обновленных международных рекомендаций. РМЖ. Медицинское обозрение. 2019;11(2):48-52. Lila A.M., Alekseeva L.I., Taskina E.A. Sovremennye podhody k terapii osteoartrita s uchetom obnovlennyh mezhdunarodnyh rekomendaciy. RMZh. Medicinskoe obozrenie. 2019;11(2):48-52. Kovari E., Kaposi A., Bekes G. et al. Comorbidity clusters in generalized osteoarthritis among female patients: A cross-sectional study. Semin Arthritis Rheum. 2019 Sep 9. pii: S0049-0172(19)30233-1. DOI: 10.1016/j.semarthrit.2019.09.001. Kovari E., Kaposi A., Bekes G. et al. Comorbidity clusters in generalized osteoarthritis among female patients: A cross-sectional study. Semin Arthritis Rheum. 2019 Sep 9. pii: S0049-0172(19)30233-1. DOI: 10.1016/j.semarthrit.2019.09.001. Дроздов В.Н., Ших Е.В., Лазарева Н.Б. Возможности снижения риска НПВП-гастропатии у больных остеоартритом. РМЖ. 2019;(12):74-78. Drozdov V.N., Shih E.V., Lazareva N.B. Vozmozhnosti snizheniya riska NPVP-gastropatii u bol'nyh osteoartritom. RMZh. 2019;(12):74-78. Шавловская О.А., Кузнецов С.Л. Инъекционная форма хондроитина сульфата в неврологической практике. Журнал неврологии и психиатрии им. С.С. Корсакова. 2019;119(5):126-133. Shavlovskaya O.A., Kuznecov S.L. In'ekcionnaya forma hondroitina sul'fata v nevrologicheskoy praktike. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2019;119(5):126-133. Lo Y.L., Sung K.H., Chiu C.C., Wang L.F. Chemically conjugating polyethylenimine with chondroitin sulfate to promote CD44-mediated endocytosis for gene delivery. Mol Pharm. 2013Feb 4;10(2):664-676. DOI: 10.1021/mp300432s. Epub 2013 Jan 14. Lo Y.L., Sung K.H., Chiu C.C., Wang L.F. Chemically conjugating polyethylenimine with chondroitin sulfate to promote CD44-mediated endocytosis for gene delivery. Mol Pharm. 2013Feb 4;10(2):664-676. DOI: 10.1021/mp300432s. Epub 2013 Jan 14. Духанин А.С. Симптом-модифицирующие препараты замедленного действия в лечении остеоартрита: от молекулы к клиническому эффекту (взгляд фармаколога). Современная ревматология. 2018;12(2):79-87. DOI: 10.14412/1996-7012-2018-2-79-87. Duhanin A.S. Simptom-modificiruyuschie preparaty zamedlennogo deystviya v lechenii osteoartrita: ot molekuly k klinicheskomu effektu (vzglyad farmakologa). Sovremennaya revmatologiya. 2018;12(2):79-87. DOI: 10.14412/1996-7012-2018-2-79-87. Балунов П.А. Сравнительный анализ применения различных вариантов дополнительной фармакотерапии при болях в спине. Медицинский совет. 2018(6):44-49. Balunov P.A. Sravnitel'nyy analiz primeneniya razlichnyh variantov dopolnitel'noy farmakoterapii pri bolyah v spine. Medicinskiy sovet. 2018(6):44-49. Coxib and traditional NSAID Trialists’ (CNT) Collaboration, Bhala N., Emberson J. et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769-779. DOI: 10.1016/S0140-6736(13)60900-9. Coxib and traditional NSAID Trialists’ (CNT) Collaboration, Bhala N., Emberson J. et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769-779. DOI: 10.1016/S0140-6736(13)60900-9. Coxib and traditional NSAID Trialists’ (CNT) Collaboration, Bhala N., Emberson J. et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769-779. DOI: 10.1016/S0140-6736(13)60900-9. Coxib and traditional NSAID Trialists’ (CNT) Collaboration, Bhala N., Emberson J. et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769-779. DOI: 10.1016/S0140-6736(13)60900-9. Curtis E., Fuggle N., Shaw S. et al. Safety of cyclo-oxygenase-2 inhibitors in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs Aging. 2019;36(Suppl. 1):25-44. DOI:10.1136/bmj.325.7365.619. Curtis E., Fuggle N., Shaw S. et al. Safety of cyclo-oxygenase-2 inhibitors in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs Aging. 2019;36(Suppl. 1):25-44. DOI:10.1136/bmj.325.7365.619. Каратеев А.Е., Насонов Е.Л., Ивашкин В.Т. и др. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации. Научно-практическая ревматология. 2018;56(Прил 1):1-29. doi.org/10.14412/rjtao20180. Karateev A.E., Nasonov E.L., Ivashkin V.T. i dr. Racional'noe ispol'zovanie nesteroidnyh protivovospalitel'nyh preparatov. Klinicheskie rekomendacii. Nauchno-prakticheskaya revmatologiya. 2018;56(Pril 1):1-29. doi.org/10.14412/rjtao20180. Bally M., Beauchamp M.E., Abrahamowicz M. et al. Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure. Pharmacoepidemiol Drug Saf. 2018;27(1):69-77. DOI: 10.1002/pds.4358. Bally M., Beauchamp M.E., Abrahamowicz M. et al. Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure. Pharmacoepidemiol Drug Saf. 2018;27(1):69-77. DOI: 10.1002/pds.4358. Julovi SM, Yasuda T, Shimizu M, et al. Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage. Arthritis Rheum. 2004 Feb;50(2):516-25. doi: 10.1002/art.20004. Julovi SM, Yasuda T, Shimizu M, et al. Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage. Arthritis Rheum. 2004 Feb;50(2):516-25. doi: 10.1002/art.20004. Gotoh S, Onaya J, Abe M, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis. 1993;52(11): 817-822. doi: 10.1136/ard.52.11.817. Gotoh S, Onaya J, Abe M, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis. 1993;52(11): 817-822. doi: 10.1136/ard.52.11.817. Pena Ede L, Sala S, Rovira JC, et al. Elastoviscous substances with analgesic effects on joint pain reduce stretch-activated ion channel activity in vitro. Pain. 2002;99(3):501-508. doi: 10.1016/S0304-3959(02)00260-9 Pena Ede L, Sala S, Rovira JC, et al. Elastoviscous substances with analgesic effects on joint pain reduce stretch-activated ion channel activity in vitro. Pain. 2002;99(3):501-508. doi: 10.1016/S0304-3959(02)00260-9 Bannuru RR, Natov NS, Dasi UR, et al. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis. Osteoarthritis Cartilarge. 2011 Jun;19(6):611-9. doi: 10.1016/j.joca.2010.09.014. Bannuru RR, Natov NS, Dasi UR, et al. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis. Osteoarthritis Cartilarge. 2011 Jun;19(6):611-9. doi: 10.1016/j.joca.2010.09.014. Алексеева ЛИ, Шарапова ЕП, Зайцева ЕМ и др. Результаты многоцентрового годичного исследования препарата дьюралан. Эффективная фармакотерапия. 2011;(37):50-7. Alekseeva LI, Sharapova EP, Zayceva EM i dr. Rezul'taty mnogocentrovogo godichnogo issledovaniya preparata d'yuralan. Effektivnaya farmakoterapiya. 2011;(37):50-7. Bannuru R.R., Osani M.C., Vaysbrot E.E. et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019 Nov;27(11):1578-1589. DOI: 10.1016/j.joca.2019.06.011. Bannuru R.R., Osani M.C., Vaysbrot E.E. et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019 Nov;27(11):1578-1589. DOI: 10.1016/j.joca.2019.06.011. Wang Z.Y., Shi S.Y., Li S.J. et al. Efficacy and safety of duloxetine on osteoarthritis knee pain: a meta-analysis of randomized controlled trials. Pain Med 2015;16(7):1373-1385. DOI: 10.1111/pme.12800. Wang Z.Y., Shi S.Y., Li S.J. et al. Efficacy and safety of duloxetine on osteoarthritis knee pain: a meta-analysis of randomized controlled trials. Pain Med 2015;16(7):1373-1385. DOI: 10.1111/pme.12800. Uchio Y., Enomoto H., Alev L. et al. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis. J Pain Res. 2018;11:809-821. DOI: 10.2147/JPR.S164128. eCollection 2018. Uchio Y., Enomoto H., Alev L. et al. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis. J Pain Res. 2018;11:809-821. DOI: 10.2147/JPR.S164128. eCollection 2018.